(Q39401468)

11 September 2017

MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin (English)

1 reference

11 September 2017

0 references

1 reference

1 reference

Ka Bian

1

1 reference

11 September 2017

Jing Fan

2

1 reference

11 September 2017

Xiang Zhang

3

1 reference

11 September 2017

Xin-Wei Yang

4

1 reference

11 September 2017

Hua-Yu Zhu

5

1 reference

11 September 2017

Lei Wang

6

1 reference

11 September 2017

Jian-Yong Sun

7

1 reference

11 September 2017

Yan-Ling Meng

8

1 reference

11 September 2017

Peng-Cheng Cui

9

1 reference

11 September 2017

Shi-Yin Cheng

10

1 reference

11 September 2017

Jian Zhang

11

1 reference

11 September 2017

Jing Zhao

12

1 reference

11 September 2017

An-Gang Yang

13

1 reference

11 September 2017

Rui Zhang

14

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 February 2012

1 reference

11 September 2017

1 reference

11 September 2017

586

1 reference

11 September 2017

6

1 reference

11 September 2017

804-809

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

MicroRNA genes are transcribed by RNA polymerase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

MicroRNA maturation: stepwise processing and subcellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

The nuclear RNase III Drosha initiates microRNA processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

Mammalian microRNAs predominantly act to decrease target mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

Prediction of mammalian microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

Molecular pathogenesis of head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

A prognostic multigene classifier for squamous cell carcinomas of the larynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

MicroRNA-203 inhibits cell proliferation by repressing ΔNp63 expression in human esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

microRNA-203 suppresses bladder cancer development by repressing bcl-w expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

Desperately seeking microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

Survivin promotes cell proliferation in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

A survivin double point mutant has potent inhibitory effect on the growth of hepatocellular cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

Induction of growth arrest by miR-542-3p that targets survivin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

High nuclear expression of the apoptosis inhibitor protein survivin is associated with disease recurrence and poor prognosis in laryngeal basaloid squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.01.050

10.1016/J.FEBSLET.2012.01.050

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference